Drug Profile
Research programme: autism therapeutic - Innovation Pharmaceuticals
Alternative Names: Autism compound - Innovation Pharmaceuticals; KM-391Latest Information Update: 09 Jun 2017
Price :
$50
*
At a glance
- Originator Unknown
- Developer Innovation Pharmaceuticals
- Class Small molecules
- Mechanism of Action Serotonin uptake modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Suspended Autistic disorder